Biomerica (BMRA) Net Income towards Common Stockholders (2010 - 2026)

Biomerica (BMRA) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 12.81% year-over-year to -$1.3 million; the trailing twelve-month figure through Feb 2026 stood at -$4.2 million (up 10.47% YoY), and the FY2025 full-year result was -$5.0 million, up 14.12% from the prior year.
• Net Income towards Common Stockholders grew to -$1.3 million in Q1 2026, from -$1.3 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $2000.0 in Q3 2025 to a low of -$2.3 million in Q2 2023.
• A 5-year average of -$1.3 million and a median of -$1.3 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders sank 1483.98% in 2023 and jumped 100.15% in 2025, its largest moves.
• Tracing BMRA's Net Income towards Common Stockholders over 5 years: stood at -$1.6 million in 2022, then rose by 7.32% to -$1.5 million in 2023, then jumped by 36.96% to -$950000.0 in 2024, then sank by 38.95% to -$1.3 million in 2025, then increased by 0.61% to -$1.3 million in 2026.
• Business Quant data shows BMRA's Net Income towards Common Stockholders at -$1.3 million in Q1 2026, -$1.3 million in Q4 2025, and $2000.0 in Q3 2025.